📖 Introduction
<h4>What is Tuberculosis?</h4><p><strong>Tuberculosis (TB)</strong> is a severe <strong>bacterial infection</strong> primarily caused by the microorganism <strong>Mycobacterium tuberculosis</strong>. It is a major global health concern, affecting millions worldwide.</p><div class='info-box'><p><strong>Key Fact:</strong> TB is one of the top 10 causes of death globally and the leading cause from a single infectious agent (above HIV/AIDS).</p></div><h4>Causative Agent</h4><p>The specific bacterium responsible for TB is <strong>Mycobacterium tuberculosis</strong>. This bacterium has unique characteristics that allow it to survive and multiply within the human body, particularly in the lungs.</p><h4>Organs Affected by TB</h4><p>While commonly associated with the lungs, <strong>Tuberculosis</strong> can practically affect almost any organ in the body. This makes it a systemic disease with diverse manifestations.</p><ul><li><strong>Lungs:</strong> The most common site of infection (pulmonary TB).</li><li><strong>Pleura:</strong> The lining around the lungs.</li><li><strong>Lymph Nodes:</strong> Often seen in children and immunocompromised individuals.</li><li><strong>Intestines:</strong> Leading to abdominal TB.</li><li><strong>Spine:</strong> Known as Pott's disease, causing bone destruction.</li><li><strong>Brain:</strong> Leading to tuberculous meningitis, a severe form.</li></ul><h4>Transmission of Tuberculosis</h4><p>TB is primarily an <strong>airborne infection</strong>. It spreads when people with active lung TB cough, sneeze, or spit, expelling TB germs into the air.</p><p>Close and prolonged contact with an infected individual is the primary mode of transmission. The risk increases significantly in certain environments.</p><div class='key-point-box'><p><strong>High-Risk Environments:</strong> Densely populated spaces with poor ventilation, such as crowded households, prisons, or public transport, facilitate the spread of <strong>Mycobacterium tuberculosis</strong>.</p></div><h4>Common Symptoms of Active Lung TB</h4><p>Recognizing the symptoms of active lung TB is crucial for early diagnosis and treatment. These symptoms can often be non-specific initially.</p><ul><li><strong>Persistent Cough:</strong> Often with sputum, and at times, blood (haemoptysis).</li><li><strong>Chest Pains:</strong> Discomfort or pain in the chest region.</li><li><strong>Weakness:</strong> General feeling of fatigue and lack of energy.</li><li><strong>Weight Loss:</strong> Unexplained and significant reduction in body weight.</li><li><strong>Fever:</strong> Low-grade fever, especially in the evenings.</li><li><strong>Night Sweats:</strong> Excessive sweating during sleep.</li></ul><h4>Treatment for Tuberculosis</h4><p><strong>Tuberculosis</strong> is a curable disease, provided that patients adhere to a full course of treatment. The standard regimen involves multiple drugs.</p><div class='info-box'><p><strong>Standard Treatment:</strong> TB is treated with a standard <strong>6-month course</strong> involving <strong>four antimicrobial drugs</strong>. This regimen is critical for effective eradication of the bacteria.</p></div><p>The treatment is usually provided under direct observation and support. A <strong>health worker</strong> or <strong>trained volunteer</strong> offers information, supervision, and support to the patient, ensuring adherence and completion of the regimen.</p><div class='exam-tip-box'><p><strong>UPSC Insight:</strong> The concept of <strong>Directly Observed Treatment, Short-course (DOTS)</strong>, a key strategy for TB control, emphasizes supervision and support to ensure treatment completion and prevent drug resistance.</p></div><h4>Challenge of Drug Resistance</h4><p>Anti-TB medicines have been in use for decades. Over time, some strains of <strong>Mycobacterium tuberculosis</strong> have developed resistance to one or more of these drugs.</p><p>This phenomenon leads to <strong>Drug-Resistant TB (DR-TB)</strong>, including <strong>Multi-Drug Resistant TB (MDR-TB)</strong> and <strong>Extensively Drug-Resistant TB (XDR-TB)</strong>, which are much harder and longer to treat, posing a significant public health challenge.</p>